Hualan Biological Engineering Inc. (SHE:002007)
15.00
+0.06 (0.40%)
Apr 15, 2026, 11:40 AM CST
SHE:002007 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 774.81 | 1,367 | 993.77 | 1,099 | 692.54 |
Short-Term Investments | 1,005 | 2,144 | 1,213 | 240 | - |
Trading Asset Securities | 2,623 | 1,888 | 2,115 | 2,369 | 2,659 |
Cash & Short-Term Investments | 4,403 | 5,398 | 4,322 | 3,708 | 3,352 |
Cash Growth | -18.44% | 24.90% | 16.56% | 10.63% | -16.72% |
Accounts Receivable | 2,078 | 2,052 | 2,590 | 2,410 | 2,097 |
Other Receivables | 6.09 | 18.66 | 6.95 | 4.84 | 7.05 |
Receivables | 2,084 | 2,071 | 3,297 | 2,759 | 2,104 |
Inventory | 2,289 | 2,029 | 1,674 | 1,447 | 1,359 |
Other Current Assets | 83.78 | 118.46 | 33.7 | 163.56 | 36.67 |
Total Current Assets | 8,859 | 9,616 | 9,327 | 8,077 | 6,851 |
Property, Plant & Equipment | 2,982 | 2,964 | 2,727 | 2,290 | 2,338 |
Long-Term Investments | 2,784 | 3,023 | 3,273 | 3,673 | 1,716 |
Goodwill | - | - | 1.1 | 1.1 | 1.1 |
Other Intangible Assets | 314.13 | 319.04 | 319.72 | 310 | 204.53 |
Long-Term Deferred Tax Assets | 196.85 | 235.34 | 241.72 | 232.49 | 201.25 |
Long-Term Deferred Charges | 55.31 | 59.69 | 59.6 | 42.49 | 55.42 |
Other Long-Term Assets | 69.79 | 92.74 | 157.3 | 116.8 | 170.16 |
Total Assets | 15,262 | 16,310 | 16,106 | 14,743 | 11,537 |
Accounts Payable | 196.26 | 217.16 | 197.26 | 175.49 | 241.03 |
Accrued Expenses | 926.54 | 914.99 | 1,169 | 1,071 | 947.5 |
Short-Term Debt | 447 | 899.73 | 700.35 | 800.38 | 800.7 |
Current Portion of Long-Term Debt | - | - | 300 | - | 10.18 |
Current Portion of Leases | 0.39 | 0.37 | 0.36 | 0.44 | - |
Current Income Taxes Payable | 18.14 | 19.58 | 63.36 | 9.7 | 48.71 |
Current Unearned Revenue | 10.21 | 13.46 | 8.57 | 14.78 | 8.28 |
Other Current Liabilities | 196.78 | 294.83 | 142.3 | 76.53 | 158.53 |
Total Current Liabilities | 1,795 | 2,360 | 2,581 | 2,148 | 2,215 |
Long-Term Debt | - | - | - | 300 | 190 |
Long-Term Leases | 8.39 | 8.78 | 9.15 | 9.3 | - |
Long-Term Unearned Revenue | 59.46 | 54.18 | 51.18 | 54.37 | 57.91 |
Long-Term Deferred Tax Liabilities | 8.11 | 40.14 | 42.82 | 20.87 | 10.37 |
Total Liabilities | 1,871 | 2,463 | 2,685 | 2,533 | 2,473 |
Common Stock | 1,827 | 1,829 | 1,829 | 1,824 | 1,824 |
Additional Paid-In Capital | 1,397 | 1,430 | 1,486 | 1,415 | 105.62 |
Retained Earnings | 8,294 | 8,633 | 8,093 | 7,159 | 6,448 |
Treasury Stock | -17.95 | -32.72 | -48.07 | - | -40.59 |
Total Common Equity | 11,501 | 11,859 | 11,359 | 10,398 | 8,337 |
Minority Interest | 1,890 | 1,988 | 2,062 | 1,812 | 727.09 |
Shareholders' Equity | 13,391 | 13,847 | 13,421 | 12,210 | 9,064 |
Total Liabilities & Equity | 15,262 | 16,310 | 16,106 | 14,743 | 11,537 |
Total Debt | 455.78 | 908.88 | 1,010 | 1,110 | 1,001 |
Net Cash (Debt) | 3,947 | 4,489 | 3,312 | 2,598 | 2,351 |
Net Cash Growth | -12.07% | 35.54% | 27.50% | 10.51% | -35.14% |
Net Cash Per Share | 2.16 | 2.46 | 1.82 | 1.42 | 1.28 |
Filing Date Shares Outstanding | 1,827 | 1,829 | 1,829 | 1,824 | 1,824 |
Total Common Shares Outstanding | 1,827 | 1,829 | 1,829 | 1,824 | 1,824 |
Working Capital | 7,064 | 7,256 | 6,745 | 5,929 | 4,636 |
Book Value Per Share | 6.29 | 6.48 | 6.21 | 5.70 | 4.57 |
Tangible Book Value | 11,186 | 11,540 | 11,039 | 10,087 | 8,131 |
Tangible Book Value Per Share | 6.12 | 6.31 | 6.04 | 5.53 | 4.46 |
Buildings | 1,808 | 1,717 | 1,302 | 1,206 | 1,256 |
Machinery | 2,714 | 2,639 | 2,504 | 2,383 | 2,433 |
Construction In Progress | 643.37 | 552.48 | 661.51 | 216.39 | 132.96 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.